DocSym
β
Searchsearch
Search
(L94.5) Poikiloderma vasculare atrophicans
More details coming soon
285 592 in individuals diagnosis poikiloderma vasculare atrophicans confirmed
1 434 deaths with diagnosis poikiloderma vasculare atrophicans
1% mortality rate associated with the disease poikiloderma vasculare atrophicans
Diagnosis poikiloderma vasculare atrophicans is diagnosed Women are 50.49% more likely than Men
70 701
Men receive the diagnosis poikiloderma vasculare atrophicans
1 434 (2.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
214 891
Women receive the diagnosis poikiloderma vasculare atrophicans
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease poikiloderma vasculare atrophicans - Men and Women aged 10-14
In Men diagnosis is most often set at age 0-89
Less common in men the disease occurs at Age 90-95+Less common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features poikiloderma vasculare atrophicans
Absence or low individual and public risk
Poikiloderma vasculare atrophicans - what does this mean
Poikiloderma vasculare atrophicans is a rare skin disorder characterized by a combination of atrophic skin changes, telangiectasias (dilated small blood vessels), and hyperpigmentation (dark patches of skin). it is caused by damage to the blood vessels in the skin, leading to inflammation and poor blood circulation.
What happens during the disease - poikiloderma vasculare atrophicans
Poikiloderma vasculare atrophicans is a rare skin condition characterized by the thickening and discoloration of the skin, caused by a combination of inflammation, atrophy, and telangiectasia. it is thought to be caused by an autoimmune response in which the body's own antibodies attack the blood vessels in the skin, leading to inflammation and eventual damage to the blood vessels. this damage then causes the skin to become thin and discolored, and the telangiectasia to appear.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Skin biopsy
- Blood tests
- X-ray
- CT scan
- Ultrasound
- MRI scan
Treatment and Medical Assistance
Main goal of the treatment: To reduce the appearance of skin lesions associated with Poikiloderma vasculare atrophicans.
- Topical corticosteroids to reduce inflammation and improve skin texture
- Topical retinoids to stimulate collagen production and reduce hyperpigmentation
- Oral retinoids to reduce inflammation and improve skin texture
- UV-A and UV-B phototherapy to reduce hyperpigmentation
- Laser therapy to reduce hyperpigmentation and improve skin texture
- Chemical peels to reduce hyperpigmentation and improve skin texture
- Dermabrasion to reduce hyperpigmentation and improve skin texture
- Topical antioxidants to reduce inflammation and improve skin texture
- Moisturizers to reduce dryness and improve skin texture
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Poikiloderma vasculare atrophicans - Prevention
Poikiloderma vasculare atrophicans is a rare skin disorder that is caused by chronic sun exposure. prevention of this condition can be achieved by limiting sun exposure, wearing protective clothing, and using sunscreen with a sun protection factor (spf) of at least 30. additionally, it is important to regularly check for new lesions and to seek medical advice if any suspicious lesions appear.